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It has been reported that oxidized LDLs (oxLDL) are involved in the pathogenesis of atherosclerosis, and
that macrophages as well as other cells of the arterial wall can oxidize LDL in vitro, depending on the
balance between intracellular prooxidant generation and antioxidant defense efﬁciency. Because of their
potential beneﬁcial role in preventing atherosclerosis and other oxidative stress-related diseases, orga-
noselenium compounds such as diphenyl diselenide (PhSe)2, are receiving increased attention. In the
present work, we investigated the mechanisms underlying the protective effect exerted by (PhSe)2 on
oxLDL-mediated effects in murine J774 macrophage-like cells. (PhSe)2 pretreatment reduced atherogenic
signaling triggered by oxLDL in macrophages in vitro, namely: ROS generation, disturbance of NO ho-
meostasis, activation of matrix metalloproteinase, foam cell formation, and mitochondrial dysfunction.
Moreover, the redox signaling effects of (PhSe)2 presented herein were accompanied by a down-
regulation of NF-kB-binding activity. The relatively strong performance of (PhSe)2 makes it an ideal
candidate for further, expanded trials as a new generation of antioxidants for preventing atherosclerotic
lesion.
 2013 Elsevier Masson SAS. All rights reserved.1. Introduction
Accumulation ofmodiﬁed low-density lipoprotein (LDL), such as
oxidized LDL (oxLDL), in the arterial wall, and the recruitment of
monocytes to the subendothelial space are known to be the main
early events in the development of atherosclerosis [1].
Blood-circulating monocytes adhere to the endothelium,
migrate to the intima, and differentiate to macrophages. Macro-
phages express receptors (CD36 and SR-A) that bind and internalize
oxidized forms of LDL, and these processes give rise to the arterial
foam cell, a hallmark of arterial lesion [2e6]. Macrophage activation
and foam cell formation are involved in both the initiation and the
progression and ultimate instability of advanced lesions. Macro-
phages taking up oxLDL could modify the production of inﬂam-
matory mediators, such as cytokines, proteases, reactive oxygen
and nitrogen species (ROS and RNS), metalloproteinases (MMPs): þ55 48 37219672.
e Bem).
son SAS. All rights reserved.[7e9] and other factors through oxidative sensitive signaling
pathways [10].
In oxLDL-stimulated macrophages, the intracellular ROS/RNS
are generated by several pathways, including the NADPH oxidase
(NOX) system, the lipoxygenase/cyclooxygenase system, inducible
NO synthase (iNOS), and mitochondrial respiratory chain [11].
Moreover, intracellular ROS generated by oxLDL stimulation can
activate a wide variety of proinﬂammatory and proapoptotic
pathways that are regulated by transcription factors, such as nu-
clear factor-kB (NF-kB) [12,13]. These events will culminate in the
death of macrophages by activation of apoptosis.
Recent clinical studies have suggested an important anti-
atherogenic role for the antioxidant enzyme glutathione peroxi-
dase (GPx) [14], which uses glutathione to reduce hydrogen
peroxide to water and lipid peroxides to their respective alcohols
[15], and it also acts as a peroxynitrite reductase [16]. Therefore, the
investigation of antiatherogenic properties of synthetic organo-
selenium compounds with GPx-mimetic activity has attracted
considerable attention. In this scenario, we have been studying the
pharmacological properties of diphenyl diselenide (PhSe)2, a
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addition to its GPx-like activity, we recently demonstrated that
(PhSe)2 is able to promote the nuclear translocation of the Nuclear
(erythroid-derived 2)-related factor (Nrf2) increasing the expres-
sion of enzymes related to antioxidant defenses, as gamma-
glutamylcysteine synthetase (GGCS) and GPx [18].
This compound was very efﬁcient in reducing the human LDL
oxidation and Cu2þ-induced lipid peroxidation in rat aortic slices
[19] and it decreased hypercholesterolemia and oxidative stress in
cholesterol-fed rabbits [20]. Furthermore, the treatment with
(PhSe)2 reduced the atherosclerotic lesion in hypercholesterolemic
LDLr /mice by modulating pathways related to antioxidant and
anti-inﬂammatory responses [21]. In the present study, we there-
fore aimed at determining whether pretreatment with (PhSe)2 at-
tenuates oxLDL-induced effects inmurine J774A.1macrophage cells
and, if so, whether the mechanisms underlying the process involve
the redox signaling pathway.
2. Materials and methods
2.1. Materials
Diphenyl diselenide (PhSe)2 was synthesized according to
published methods [22]. Analysis of the 1H NMR and 13C NMR
spectra showed that the compound obtained presented analytical
and spectroscopic data in full agreement with its assigned struc-
ture. The chemical purity of (PhSe)2 (99.9%) was determined by GC/
HPLC. All other chemicals were of analytical grade and obtained
from standard commercial suppliers.
2.2. LDL isolation and oxidation
This study was approved by our Ethic Committee at Federal
University of Santa Catarina (n 943/11). LDL was isolated from
fresh human plasma by discontinuous density-gradient ultracen-
trifugation as previously described [19] and the protein concen-
tration in LDL solution was determined by Lowry [23]. LDL isolated
samples (1 mg of protein/mL) were oxidized at 37 C in the pres-
ence of 10 mMCuSO4 for 16 h, to produce oxLDL. Then EDTA 1.5 mM
was added and the samples were dialyzed against 148 mM phos-
phate buffer for 24 h at 4 C. LDL oxidation was monitored by
following the thiobarbituric acid-reactive substances (TBARS)
production.
2.3. Cell culture
Murine J774A.1 macrophage cells were obtained from the
American Type Culture Collection (ATCC, Rockville, MD, USA). These
cells were maintained with Dulbecco’s Modiﬁed Eagle Medium
(DMEM) supplemented with 2 mM glutamine, 10 mM HEPES,
100 units/mL penicillin, 100 mg/mL streptomycin and 10% fetal
bovine serum (FBS) in a 5% CO2 humidiﬁed atmosphere at 37 C.
The exposition of cells with (PhSe)2 and/or oxLDLwas carried out in
DMEM without FBS.
2.4. Measurement of reactive oxygen species (ROS) production
Intracellular ROS production was detected using the non-
ﬂuorescent cell permeating compound, 20,70-dichlorodihydro-
ﬂuorescein diacetate (DCFH-DA). In order to evaluated the protec-
tive effect of (PhSe)2 on ROS production induced by oxLDL,
macrophage (2.0  105 cells/well) seeded in 24 well plates were
ﬁrstly stimulated to an increasing concentration curve of oxLDL (25,
50,100 and 200 mg/mL) for 1 h. After that, cells were incubatedwith
DCFH-DA (10 mM) for 30 min at 37 C, washed twice with PBS,harvested and collected for immediate determination of ROS gen-
eration by ﬂow cytometry (FACS Canto II, BD Bioscience, United
States). The protective effect of (PhSe)2 was also evaluated by ﬂow
cytometry by pretreating cells for 24 h with (PhSe)2 (1 mM) or
vehicle before oxLDL (100 mg/mL) stimulation for 1 h. The results
were expressed as percentage of control (non-stimulated cells;
100%).
2.5. Measurement of mitochondrial membrane potential (DJm)
The mitochondrial membrane potential (DJm) was assessed
using the lipophilic cationic probe ﬂuorochrome JC-1 [24]. In
presence of physiological mitochondrial membrane potentials, JC-1
forms aggregates that ﬂuoresce with an emission peak at 588 nm.
Loss of membrane potential favors the monomeric form of JC-1,
which has an emission peak at 530 nm. To examine the effect of
(PhSe)2 on modiﬁcations in DJm induced by oxLDL, macrophages
were plated into 24well plates (2.0 105 cells/well) and pretreated
with (PhSe)2 (1 mM) or vehicle for 24 h, followed by stimulation
with oxLDL (100 mg/mL) or FCCP 1 mM (a positive control) for
additional 3 h. After, macrophages were incubated with JC-1 (5 mM)
for 20 min at 37 C and JC-1 ﬂuorescence intensity was measured
using a ﬂuorometric microplate reader (Tecan, Grödig/Salzburg,
Austria) with excitation at 488 nm and an emission at 525 nm and
590 nm. Mitochondrial membrane potential was inferred from the
ratio of ﬂuorescence intensity red/green. The images were acquired
from three randomly chosen ﬁelds using an inverted epiﬂuor-
escence microscope (Olympus IX70).
2.6. Cell viability assay
The cell viability in the presence or absence of (PhSe)2 was
measured by MTT assay as described by Siqueira and cols [25].
Macrophage (1  104 cells/well) seeded in 96 well plates were
pretreated with (PhSe)2 (1 mM) or vehicle for 24 h, followed by
stimulation with oxLDL (100 or 200 mg/mL) for additional 24 h.
After this, 200 mL of MTT solution (0.5 mg/mL) was added and
incubated for 2 h. Then, theMTTwas removed and 200 mL of DMSO/
well was added to dissolve the intracellular crystalline formazan
product. The absorbance at 550 nm was read spectrophotometri-
cally using a microplate reader. The results were expressed as a
percentage of the absorbance of non-treated cells.
2.7. Foam cell formation assay
Foam cell formation assay was performed with the Oil Red O
staining method [26]. Macrophages (2.5  105 cells/well) plated in
coverslip in 12 wells plate were pretreated with (PhSe)2 (1 mM) or
vehicle for 24 h, and then stimulated with oxLDL (100 mg/mL) for
additional 3 h. Following oxLDL incubation, cells were ﬁxedwith 4%
paraformaldehyde and stained by 0.3% Oil Red O for 10 min. He-
matoxylin was used as counterstaining. Images of cells were ac-
quired using confocal microscopy (Leica DMI6000 B Microscope)
using a 546 nm ﬁlter set. Ten images were captured from each
group and the total pixels intensity was determined using NIH
Image J 1.36b imaging software (National Institutes of Health,
Bethesda, MD, USA), and lipid content was expressed as optical
density (OD).
2.8. MMP activity measurement
Matrix metalloproteinases (MMPs) are a family of zinc-
dependent endopeptidases, capable of degrading all the molecu-
lar components of extracellular matrix. To evaluate the activity of
MMP-9, we used two different techniques, gelatin zymography and
Fig. 1. (PhSe)2 decreases the oxLDL-induced ROS production in macrophages. (A) Macrophages were exposed to different concentrations of oxLDL (25e200 mg/mL) for 1 h. (B) The
macrophages were pretreated with (PhSe)2 or vehicle for 24 h and exposure to oxLDL (100 mg/mL) for additional 1 h. DCFH-DA (10 mM) was added to the medium for 30 min and the
amount of ROS was determinate by ﬂow cytometry. The ROS amount was expressed as percentage of increase of control. (C) Representative ﬂow cytometer histogram. Each bar
represents the mean  SEM of at least three independent experiments. *P < 0.05; **P < 0.01; ***P < 0.001 indicates the difference when compared with control; ##P < 0.01 indicates
the difference when compared with oxLDL exposure cells (one-way ANOVA, Duncan’s test).
Fig. 2. (PhSe)2 prevents oxLDL-mediated mitochondrial dysfunction. Macrophages were pretreated 24 h with (PhSe)2 (1 mM) or vehicle and then exposed to oxLDL (100 mg/mL) for
additional 3 h. FCCP (1 mM) was utilized as a positive control. (A) The change in mitochondrial membrane potential (DJm) was assessed based on the signal intensity from JC-1
monomeric and aggregate ﬂuorescence (Magniﬁcation 400). (B) JC-1 ﬂuorescence was quantiﬁed ﬂuorometrically. Each bar represents the mean  SEM of the ratio (red/green
ﬂuorescence) of at least three independent experiments. ***P < 0.001 indicates the difference when compared with control; ##P < 0.01 indicates the difference when compared
with oxLDL exposure cells (one-way ANOVA, Duncan’s test).
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Fig. 3. OxLDL-induced cytotoxicity was prevent by (PhSe)2. Macrophages were treated
24 h with (PhSe)2 1 mM or vehicle and then exposed to oxLDL (100 mg/mL or 200 mg/
mL) for additional 24 h. The cell viability was determined by MTT assay and expressed
as percentage of control. Each bar represents the mean  SEM of at least three inde-
pendent experiments. ***P < 0.001 indicates the difference when compared with
control; #P < 0.05 indicates the difference when compared with oxLDL exposure cells
(one-way ANOVA, Duncan’s test).
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well) were seeded in 12 wells plate and then preincubated with
(PhSe)2 (1 mM) or vehicle for 24 h, followed by stimulation with
oxLDL (100 mg/mL) for additional 24 h.
2.8.1. Gelatin zymography
Supernatants (50 mg/mL of total protein) were subjected to SDS-
PAGE in 7.5% (w/v) polyacrylamide gels copolymerized with 1.5%
gelatin as a substrate as previously described [27]. After electro-
phoresis, the gels were stained with Coomassie Brilliant Blue.
Proteolytic activity in a particular gel location yielded a clear band
against the blue background of the stained gelatin. The MMP-9
were identiﬁed by molecular size using high-molecular mass
(92 kDa) standards (Bio-Rad, Hercules, CA, USA). Gels were scanned
and the intensity of the bands was quantiﬁed using Quantity One
software (Bio-Rad, Hercules, CA, USA). The results were expressed
as intensity of MMP-9 relative to control.
2.8.2. EnzChek Gelatinase/Collagenase assay kit
The activity of gelatinase or collagenase IV in conditioned su-
pernatants was determinate using an Enzymatic Gelatinase/Colla-
genase ﬂuorometric assay kit (Molecular Probes, USA). Brieﬂy,
conditioned supernatants (50mg/mLof protein)were incubatedwith
MMP speciﬁc peptide substrate, based on the instructions included
with the kit. The cleavage of substrates by MMP (gelatinases or
collagenase IV) result in increased ﬂuorescence signal measured
using a ﬂuorescence microplate reader (Tecan, Grödig/Salzburg,
Austria)with excitationat495nmandemissionat515nm.Datawere
reported as the collagenase IV activity relative to the control.2.9. iNOS expression
The expression of iNOS was evaluated by western blot analysis.
Macrophages (5.0 105 cells/well) were seeded in 6wells plate and
then preincubated with (PhSe)2 (1 mM) or vehicle for 24 h, followed
by stimulationwith oxLDL (100 mg/mL or 200 mg/mL) for additional
24 h. Proteins were subjected to 7.5% SDS-PAGE, transferred to
nitrocellulose membranes and blocked with 5% low fat milk in
50 mM PBS for 1 h. Membranes were then probed at room tem-
perature, for 1 hwith rabbit polyclonal anti-iNOS antibody (1:2000,
Santa Cruz Biotechnology, USA). For the detection, immunocom-
plexed membranes were washed in PBS containing 0.6% Tween 20,and probed with goat anti-rabbit antibody at room temperature for
1 h (1:5000, Santa Cruz Biotechnology, USA). After extensive
washing, blots were visualized using the Perkin Elmer ECL system.
Equal loading of gel lanes was veriﬁed by probing the blots for b-
actin content. The intensity of the bands was quantiﬁed using
Quantity One software (Bio-Rad, Hercules, CA, USA).
2.10. Nitrite assay
Nitrite production, an indicator of NO production, was measured
in the conditioned culture medium by the Griess reaction [28]. Mac-
rophages (2.0  105 cells/well) were cultured in 24 well plates and
preincubated with (PhSe)2 (1 mM) or vehicle for 24 h and then stim-
ulated with oxLDL (100 or 200 mg/mL) for additional 24 h. The su-
pernatantswere collected to quantiﬁcation of nitrite. Brieﬂy,100 mL of
supernatants were mixed with 100 mL of Griess reagent (equal vol-
umes of 1% (w/v) sulphanilic acid in 30% (v/v) acetic acid and 0.1% (w/
v)N-(1-naphthyl) ethylenediamine in60% (v/v) acetic acid), incubated
at room temperature for 30 min in the dark, and the absorbance at
540nmwasmeasured inamicroplate reader (Tecan, Grödig/Salzburg,
Austria). The amount of nitrite was calculated from a standard curve
using freshly prepared sodium nitrite in culture medium and the re-
sults were expressed as percentage of control (non-treated cells).
2.11. Immunoﬂuorescence (immunohistochemistry)
The effect of (PhSe)2 on oxLDL-induced NF-kB nuclear trans-
location was evaluated by immunoﬂuorescence. Macrophages
(2.5  105 cells/well) seeded in coverslips in 12 wells plate were
preincubated with (PhSe)2 (1 mM) or vehicle for 24 h, followed by
stimulation with oxLDL (100 mg/mL) or vehicle for additional 1 h.
After which cells were ﬁxed with 4% paraformaldehyde and
blocked with 4% of albumin in 0.05% (v/v) Tween 20-PBS (PBS-T20)
for 15 min. The nuclear translocation of NF-kB was evaluated by
immunoﬂuorescence using an anti-NF-kB rabbit monoclonal p-65
antibody (1:100, Santa Cruz Biotechnology, USA) in PBS-T20 for
24 h at 4 C, followed by FITC conjugated donkey anti-rabbit IgG
secondary antibody (1:100, Santa Cruz Biotechnology, USA) for 1 h.
Cell nuclei were stained with Hoechst 33258. The images were
acquired from eight to ten randomly chosen ﬁelds using a ﬂuo-
rescent microscope (Olympus BX41).
2.12. Statistical analysis
All data are expressed as mean  SEM from at least three inde-
pendent experiments. Differences betweenmean values ofmultiple
groups were analyzed by one-way analysis of variance (ANOVA)
followed by the post-hoc Duncan multiple range test when P was
signiﬁcant. Statistical signiﬁcance was considered at P < 0.05.
3. Results
3.1. (PhSe)2 prevents the oxLDL-induced ROS production,
mitochondrial dysfunction and cell death
As expected, the exposition of J774A.1macrophage cells for 1 h to
oxLDL (25e200 mg/mL) caused a concentration-dependent
(b ¼ 0.861, P < 0.001) increase on intracellular ROS production
(Fig. 1A). The pretreatment of macrophages with (PhSe)2, signiﬁ-
cantly attenuated the oxLDL-inducedROSproduction (Fig.1B andC).
Mitochondrial dysfunction and the ensuing bioenergetic
impairment are likely to promote ion pump failure and loss of
mitochondrial membrane integrity. Mitochondrial membrane po-
tential (DJm) was analyzed by JC-1 ﬂuorescence. OxLDL (100 mg/
mL) signiﬁcantly induced a decrease in DJm, by reducing the
Fig. 4. (PhSe)2 inhibits the oxLDL-mediated foam cell formation. Macrophages were treated 24 h with (PhSe)2 1 mM or vehicle and then exposed to oxLDL (100 mg/mL) for additional
3 h followed by stained with Oil Red O. (A) Representative confocal micrographs of Oil Red O-derived ﬂuorescence in macrophage (Magniﬁcation 63). (B) Quantiﬁcation of foam
cells lipid content (arbitrary units, a.u.). Each bar represents the mean  SEM of at least three independent experiments. **P < 0.01 indicates the difference when compared with
control and ##P < 0.01 indicates the difference when compared with oxLDL exposure cells (one-way ANOVA, Duncan’s test).
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tion. The pretreatment of macrophages with (PhSe)2 prevents
oxLDL-mediated mitochondrial dysfunction (Fig. 2A and B). FCCP
(1 mM), a known depolarizing agent, was used as a positive control.
To investigate the potential beneﬁcial effects of (PhSe)2 on
oxLDL-mediated toxicity in macrophage, the cell viability was
evaluated by the MTT assay. As shown in Fig. 3, the exposure of
macrophage to oxLDL (200 mg/mL) for 24 h signiﬁcantly decreased
(y 46%) the cell viability and (PhSe)2 pretreatment prevented this
cytotoxic effect. The exposure of macrophage to oxLDL 100 mg/mL
did not decrease the cell viability.3.2. (PhSe)2 modulates oxLDL-induced foam cells formation and
MMP-9 activation
The Oil Red O staining is ample used to detect the lipid droplets
accumulation in cells. As expected, the 3 h oxLDL (100 mg/mL)
exposure induced its uptake by macrophages and the consequent
foam cell formation. The pretreatment with (PhSe)2 signiﬁcantly
reduced the uptake of oxLDL by macrophages (Fig. 4).
Since it has been reported that oxLDL triggered the metal-
loproteinase activation we focus on the effect of (PhSe)2 in this
enzymatic system. First, we veriﬁed that the pretreatment with
(PhSe)2 signiﬁcantly reduced the increment of the collagenase IV
activity, that included the MMP-2 and MMP-9 activities, in the
conditioned medium after 24 h of oxLDL (100 mg/mL) exposition
(Fig. 5A). In the same way, Fig. 5B shows a representative zymog-
raphy analysis, where it can be observed that oxLDL produced a
signiﬁcant increase in MMP-9 activity that were markedly attenu-
ated by (PhSe)2 pretreatment.3.3. (PhSe)2 modulates oxLDL-induced iNOS expression,
NO
production and NF-kB nuclear translocation
It is known that iNOS mediated the excessive nitric oxide syn-
thesis in inﬂammatory conditions. In this way, oxLDL (200 mg/mL)induced an increase in iNOS expression with consequent NO
increased levels in macrophages. Both process were attenuated by
the (PhSe)2 pretreatment (Fig. 6A and B, respectively).
As preview reported, here we demonstrated that the exposure
of oxLDL (100 mg/mL) for 1 h induced the NF-kB activation in
macrophages. The pretreatment with (PhSe)2 blocked the NF-kB
nuclear translocation retaining this factor in the cytoplasm (Fig. 7).4. Discussion
In this study, we demonstrated that (PhSe)2 is capable of pre-
venting several events related to toxicity following oxLDL-
stimulation of macrophages.
To determine the effect of oxLDL in oxidative stress, ROS pro-
duction was evaluated (Fig. 1). In agreement with the results
already reported, acute oxLDL exposure increases the production of
intracellular ROS/RNS in macrophages [11,29].
Taking into account the exacerbated production of ROS in
atherosclerosis, the investigation of organoselenium compounds
with GPx-like activity is relevant. When macrophages were pre-
treated with (PhSe)2, ROS generation induced by oxLDL signiﬁ-
cantly decreased (Fig. 1B and C), indicating that this compound has
antioxidant properties, as previously described [17]. Accordingly,
Rosenblat and Aviram [30] have demonstrated that chemical inhi-
bition of GPx-1 activity in macrophages results in increased cellular
peroxide and superoxide production.
ROS and RNS can easily affect the mitochondria, whereas these
organelles also generate species by themselves [31]. Earlier studies
demonstrated that oxLDL decreases mitochondrial respiratory
chain activities and induces ROS overproduction in endothelial cells
[32]. In the present study, we found that oxLDL induced damage to
mitochondrial function by decreasing DJm in macrophages cells.
Corroborating our results, Asmis and Begley [33] showed that the
exposure to oxLDL impairs mitochondrial function and induces
apoptosis and cell lysis in human macrophages. Here, the pre-
treatment with (PhSe)2 prevented mitochondrial damage,
Fig. 5. (PhSe)2 modulates oxLDL triggered MMP-9 activity. Macrophages were treated
24 h with (PhSe)2 1 mM or vehicle and then exposed to oxLDL (100 mg/mL) for addi-
tional 24 h. (A) The collagenase IV activity in the supernatant was measured using an
EnzChek Gelatinase/Collagenase Assay kit. (B) Zymography analysis of MMP-9 activity
in cell supernatant. Upper panel: representative zymography assays of MMP-9 gelat-
inolytic activity. Lower panel: densitometry analysis from zymography assays. Results
were expressed as relative intensity to control. Each bar represents mean  SEM of at
least three independent experiments. ***P < 0.001 compared with control and
##P < 0.01; ###P < 0.001 indicates the difference when compared with oxLDL exposure
cells (one-way ANOVA, Duncan’s test).
Fig. 6. Effect of (PhSe)2 on oxLDL-induced iNOS expression and
NO production.
Macrophages were treated 24 h with (PhSe)2 1 mM or vehicle and then exposed to
oxLDL (100 mg/mL or 200 mg/mL) for additional 24 h. (A) Representative western blot
analysis of iNOS. b-actin was used as a load control. (B) Nitrite levels in the conditioned
culture medium and expressed as percentage of control. Each bar represents the
mean  SEM of at least three independent experiments. *P < 0.05; ***P < 0.001
compared with control and #P < 0.05; ###P < 0.001 indicates the difference when
compared with oxLDL (200 mg/mL) exposure cells (one-way ANOVA, Duncan’s test).
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uted to its antioxidant properties. In agreement with this, recent
studies have demonstrated that (PhSe)2 restores the mitochondrial
dysfunction caused by acetaminophen [34] and by methylmercury
[35] inmouse brain. This ROS overproduction can be responsible for
triggering different pathways related to cell death [36], which can
occur either by mitochondrial dysfunction or by downregulation of
anti-apoptotic proteins [37]. In accordance with this, here the ROS
production and mitochondrial dysfunction promoted by oxLDL
were associated with a decrease in macrophage viability, which
was prevented by (PhSe)2 treatment (Fig. 3). These evidences
support the hypothesis that (PhSe)2 could prevent the cytotoxic
effects mediated by oxLDL in macrophage by inhibit ROS
generation.
NF-kB and Activator protein-1 (AP-1) are two redox-sensitive
transcription factors that can be activated during variousinﬂammatory disease processes [38]. The activation of these tran-
scription factors can up regulate several major proinﬂammatory
mediators such as iNOS, MMPs, CD36 receptor and others [36,39e
41]. The NF-kB pathway is an attractive candidate to mediate the
effects of ROS because the interaction between the inhibitory
protein IkB and NF-kB is regulated by protein kinases that contain
several redox-sensitive cysteine residues in critical kinase domains
[42]. In addition, H2O2 stimulation enhanced the nuclear trans-
location of AP-1 and NF-kB subunits [43]. Wiesner et al. [44]
demonstrated, by exposure of macrophages to the minimally
oxidized LDL (mmLDL) and lipopolysaccharide (LPS), that the
cooperative engagement of NF-kB and AP-1 results in additive/
synergistic increased transcription of inﬂammatory cytokines
within atherosclerotic lesions. Here, we showed that the exposure
of macrophages to oxLDL can rapidly (1 h) lead to the activation of
Fig. 7. (PhSe)2 modulates oxLDL-induced NF-kB nuclear translocation. Macrophages
were treated 24 h with (PhSe)2 1 mM or vehicle and then exposed to oxLDL (100 mg/mL)
for additional 1 h. Nuclear translocation of NF-kB was evaluated by immunoﬂuores-
cence (green). Nuclear counterstaining was made with Hoechst 33258 (blue). A
representative merge of the two ﬂuorescence images (green and blue) is shown
(Magniﬁcation 1000). The representative images were from three independent
experiments.
Scheme 1. Effects of (PhSe)2 on macrophage oxLDL-induced toxicity. Based on the
results appointed in this study, we conclude that the (PhSe)2 decreased the ROS
generation and LDL uptake in macrophages. Moreover, the pretreatment with the
organoselenium compound prevented the decrease in DJm and the consequently cell
death induced by oxLDL. In addition, the NF-kB translocation to the nucleus was
blocked by (PhSe)2, diminishing the transcription of genes such as CD36 receptor, iNOS
and MMP-9, resulting in a decreasing expression of these proteins and NO production.
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the (PhSe)2 treatment led to a downregulation of NF-kB-binding
activity. Consistent with this, we recently demonstrated that the
oxLDL-mediated increase in TNF-a and MCP-1, inﬂammatory me-
diators trigged by the NF-kB activation, was prevented by (PhSe)2 in
macrophage [21].
It has been documented that macrophages express high levels of
MMPs, mainly theMMP-2 andMMP-9, in response to oxidative and
inﬂammatory stimulus. These MMPs are highly expressed in
vulnerable regions of atherosclerotic plaques and are involved in
the remodeling processes associated with atherogenesis and pla-
que rupture [45,46]. Herein, we showed by two different method-
ological approaches that oxLDL induced a markedly increase in
speciﬁc MMP-9 and collagenase IV activities, which was attenuated
by the pretreatment with (PhSe)2 (Fig. 5). We elected to evaluate
only the speciﬁc activity of MMP-9 because its increase is more
evident than the others MMPs isoforms [47]. Then, based on our
results we can’t discard that the increase in collagenase IV activity
could be a reﬂex of the sum of theMMP-2 andMMP-9 activities and
that pretreatment with (PhSe)2 was able of attenuating bothMMPs.
Nitric oxide (NO) is known to counteract the atherogenic pro-
cess bymediating vasorelaxation, reducing vascular smoothmuscle
cell proliferation, and decreasing platelet aggregation [48]. A recent
study shows that oxLDL enhances the expression of iNOS and NO
production in macrophages [49]. In our experimental condition,
exposure of macrophages to oxLDL caused a signiﬁcant increase in
both iNOS protein expression and NO levels, while pretreatment
with (PhSe)2 prevented it (Fig. 6A and B). Consistent with these
observations, Shin et al. [50] reported that another diselenide, bis-
(3-hydroxyphenyl) diselenide (DSE-B), potently inhibits NO pro-
duction and decreases iNOS protein levels in macrophages stimu-
lated with LPS. Recently, Rupil et al. [51] showed that (PhSe)2
inhibits the NO production in a dose-dependent mode in perito-
neal macrophages activated by LPS and this effect was correlated
with a decrease in iNOS expression.
The internalization of oxLDL in macrophages occurs through
mechanisms involving different cell surface receptors; in this
context, the CD36 has an important role [52]. In this study, we
demonstrated that (PhSe)2 efﬁciently decreased oxLDL uptake andconsequent foam cell formation (Fig. 4). This effect can be explained
by the inhibition of the activation of NF-kB by the organoselenium
compound with consequent decrease in the expression of CD36,
resulting in less uptake of oxLDL.
Taken together, the effects of (PhSe)2 here presented, are
possibly related to its antioxidant property. We believe that, the
downregulation in oxLDL-mediated free radical generation could
provide a favorable cellular environment that avoid NF-kB activa-
tion and the consequent cell death. This potent antioxidant effect of
(PhSe)2 may be explained in part to its ability in decomposing
organic hydroperoxides of oxLDL via GPx-mimetic activity. By the
other hand, this organoselenium compound could be acting via
Nrf2, which increases the expression of phase II antioxidant genes
leading to an improvement in cellular redox environment [53]. This
hypothesis is supported by our recent study that reported an
improvement in glutathione antioxidant system mediated by
(PhSe)2 via Nrf2 activation [18].5. Conclusion
In this study, we provide evidence that (PhSe)2 protects mac-
rophages against atherogenic signaling triggered by oxLDL by
inhibiting ROS generation and ROS-induced inﬂammatory path-
ways modulated by NF-kB (Scheme 1). Our ﬁndings suggest that
(PhSe)2 might be a candidate agent for further developments in the
prevention of cardiovascular diseases.Conﬂicts of interest
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